Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study

about

Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study

Item

http://www.wikidata.org/entity/Q58804239

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Real-World Safety of Intravitr ...... rospective Observational Study

@en

Real-World Safety of Intravitr ...... rospective Observational Study

@nl

type

Item

label

Real-World Safety of Intravitr ...... rospective Observational Study

@en

Real-World Safety of Intravitr ...... rospective Observational Study

@nl

prefLabel

Real-World Safety of Intravitr ...... rospective Observational Study

@en

Real-World Safety of Intravitr ...... rospective Observational Study

@nl

P1476

Real-World Safety of Intravitr ...... rospective Observational Study

@en

P2093

Apichart Singalavanija

http://www.w3.org/2001/XMLSchema#string

Claudia Geue

http://www.w3.org/2001/XMLSchema#string

Kittisak Kulvichit

http://www.w3.org/2001/XMLSchema#string

Lily Ingsrisawang

http://www.w3.org/2001/XMLSchema#string

Paisan Ruamviboonsuk

http://www.w3.org/2001/XMLSchema#string

Pattara Leelahavarong

http://www.w3.org/2001/XMLSchema#string

Prut Hanutsaha

http://www.w3.org/2001/XMLSchema#string

Sermsiri Sangroongruangsri

http://www.w3.org/2001/XMLSchema#string

Suthasinee Kumluang

http://www.w3.org/2001/XMLSchema#string

Tanapat Ratanapakorn

http://www.w3.org/2001/XMLSchema#string

P2860

A safety review and meta-analyses of bevacizumab and ranibizumab: off-label versus goldstandard

Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration

The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

A systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections.

P304

853-865

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40261-018-0678-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Olivia Wu

Janejit Choovuthayakorn

Usa Chaikledkaew

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30069864

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

An Téalainn

P932

6153972

http://www.w3.org/2001/XMLSchema#string